Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by GajjarDron Jan 10, 2018 1:42pm

151 Views

Post# 27325522

RE:Just makes me realize more and more

I'm out on NF too much manipulation,been watching the orders and know what's happening. TFS, Telferscot Resources is right now the cheapest MJ stock on the CND market I've been eating these cheapies yesterday and today.

wdr522266 wrote: How these markets are manipulated by the banksters and the big players.At any given moment in time these people can make or break a stock.Dosn't matter what the fundamentals of the company are at all.
wdr2

Great read below regarding TFS, & their 'in the works' aquisation taking place. CANNATAB & Emblem $$$$$$$$$$$-$$$$$$$$$$$

makeshift wrote:
Hi. Long time Stockhouse reader, only recently started an account to tune out some of the noise. I thought I would help clarify the LOI since the messages on this board are a bit all over the place.

Full disclosure, I own many shares in TFS.

I recently emailed TFS directly and received a very prompt response. I'm simply repeating what I've been told.

1. TFS shares will consolidate 200 to 1. So if the share price is 0.07 cents when it consolidates, you'll own 1 share worth $14.

2. Telferscot Resources will buy out Canntab shares at a rate of 4 TFS shares to 1 Canntab share. This has NOTHING to do with our TFS shares. It's how Telferscot is acquiring Canntab. Here, 1.6.1 is most likely correct about Canntab wanting to use TFS to go public. Read his/her post.

3. Canntab will raise $5 million by issuing 1,250,000 of their own shares much like a PP (possibly even a PP). The $4 price is set to attract investors and does not reflect the actual share price. It's usually set lower so investors will earn their money back. Again, this has nothing to do with our TFS shares but a condition of acquiring Canntab.

4. The 24.4 million shares resulting is a combination of the existing TFS shares (consolidated 200:1) and the acquired Canntab shares.

So at the current share price of 0.07 cents... is Canntab worth $14 a share and should their market cap be roughly $340 million? I look at other mj companies with a lot less going on... no license, facility under construction, etc. easily having market caps of $340 million+. Canntab has a definitive deal with Emblem (already licensed) and more.

GLTA